Activation of the mammalian immune system by siRNAs
- 4 November 2005
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 23 (11) , 1399-1405
- https://doi.org/10.1038/nbt1161
Abstract
Inhibition of gene expression through RNA interference (RNAi) is emerging as a powerful experimental tool for gene function and target validation studies. The potential uses of this technology seem unlimited, extending to the prevention and therapy of human diseases. However, recent work demonstrating that there are unanticipated, different nonspecific effects associated with the use of small interfering RNAs in mammals has raised concerns about the safe use of RNAi in vivo. These nonspecific effects include activation of the immune system, potentially harming the individual. The application of screening assays for nonspecific activation of both innate and acquired immunity will be necessary for further development of RNAi as a therapeutic tool.Keywords
This publication has 75 references indexed in Scilit:
- The evolution of vertebrate Toll-like receptorsProceedings of the National Academy of Sciences, 2005
- MicroRNA biogenesis: coordinated cropping and dicingNature Reviews Molecular Cell Biology, 2005
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005
- Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationJournal of Molecular Biology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- RNA silencing in plantsNature, 2004
- Mechanisms of gene silencing by double-stranded RNANature, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- RNAi Therapeutics: How Likely, How Soon?PLoS Biology, 2004
- The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamilyEuropean Journal of Immunology, 2003